This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,236.27, is for the delivery of the specialty medication Skyrizi (360 mg/2.4 ml on-body) with a completion date of December 20, 2024. This is a firm fixed-price delivery order contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's critical role in supplying essential medical products to federal government agencies, particularly within the military and veterans' healthcare systems.
Generated 2/28/25, 9:52 AM